Results 141 to 150 of about 74,283 (261)

Barriers to better three‐dose coverage with HPV vaccination in school‐based programs

Australian and New Zealand Journal of Public Health, 2014
Maureen Watson, John Lynch, Katina D'Onise, Julia Brotherton   +3 more
doaj   +1 more source

Application of the Health Belief Model to Understand the Factors Associated with Chinese International Students’ HPV Vaccine Uptake

Youth
Guided by the Health Belief Model (HBM), this cross-sectional quantitative study investigated the relationship between key factors and HPV vaccine uptake among Chinese international students (CISs).
Weiqi Chen, Elizabeth Reifsnider, Cheng-Ching Liu, Angela Chia-Chen Chen   +3 more
doaj   +1 more source

Public Health Achievements in Rwanda: A 21st Century Transformation

Public Health Challenges, Volume 5, Issue 2, June 2026.
This narrative review examines Rwanda's post‐2000 public health transformation using the WHO health system building blocks. It shows how strategic governance, universal health coverage via mutuelle de santé, community health workers, and digital health tools have driven substantial gains in maternal/child health, infectious disease control, and ...
Niyibizi Julius, Mugisha John, Nizeyimana Emmanuel   +2 more
wiley   +1 more source

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes. [PDF]

, 2019
BackgroundHuman papillomaviruses (HPV) cause over 500 000 cervical cancers each year, most of which occur in low-resource settings. Human papillomavirus genotyping is important to study natural history and vaccine efficacy. We evaluated TypeSeq, a novel,
Boland, Joseph, Cortes, Bernal, Cullen, Michael, CVT Group, Dunn, S Terence, Herrero, Rolando, Hildesheim, Allan, Kreimer, Aimée R, Mirabello, Lisa, Porras, Carolina, Quint, Wim, Roberson, David, Rodriguez, Ana Cecilia, Sampson, Joshua, Schiffman, Mark, Van Doorn, Leen-Jan, Wagner, Sarah, Walker, Joan, Wentzensen, Nicolas, Yeager, Meredith, Zuna, Rosemary   +20 more
core   +1 more source

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, Volume 20, Issue 5, Page 1098-1110, May 2026.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

Partnership Driving Impact: An Integrated Women‐Centric Model to Improve Early Detection and Treatment of Cervical and Breast Cancer in Ghana and India

Cancer Medicine, Volume 15, Issue 5, May 2026.
This manuscript focuses on the design and implementation of 2 real‐world screening programs conducted in Ghana and India. These programs were developed to align with the operational realities and resource constraints of each setting, prioritizing approaches that are both sustainable and scalable for long‐term cancer control.
Mary Efua Commeh, Nuzhat Husain, Christabel Boaduwaa Afrane, Mavis Apatu, Amos Asiedu, Margaret Mary Bertram, Parag Bhamare, Nimrit Kaur, John Kafui Klu, Christina Lorenz, Maura McCarthy, Louisa Preko, Stephanie Sassman, Blessing Tawari, Joni Zurawinski, Keith Dawson   +15 more
wiley   +1 more source

Influences on college health provider practice for routinely screening female college students’ HPV vaccination status

BMC Public Health
Background HPV vaccination is highly effective in preventing HPV infection and subsequent precancers and invasive cancers related to HPV. Unfortunately, vaccine coverage in the U.S. lags behind national and global targets.
Erica Liebermann, Bing Si, M. Katherine Hutchinson, Bo Li, Melissa A. Sutherland   +4 more
doaj   +1 more source

Computational Design of an mRNA Vaccine Targeting LRP6 for Triple‐Negative Breast Cancer Therapy

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Triple‐negative breast cancer (TNBC) presents a poorer prognosis than other breast cancer subtypes, attributed to its aggressive nature and the lack of specific therapeutic interventions. TNBC has high recurrence rates and limited survival despite current therapies, emphasizing the critical need for improved treatment options.
Pooriya Teimoori, Mohammadreza Heidari
wiley   +1 more source

Expression of Programmed Death‐Ligand 1 in Cervical Cancer: Correlation With Histologic Subtypes and Clinicopathological Features

Immunity, Inflammation and Disease, Volume 14, Issue 5, May 2026.
ABSTRACT Background Cervical cancer remains a significant global health challenge, with squamous cell carcinoma (SCC) and adenocarcinoma representing its predominant histologic types. Programmed death‐ligand 1 (PD‐L1) expression in cervical cancer has been implicated in tumor immune evasion, yet its prognostic significance remains unclear.
Zahra Vahedpoor, Amirhasan Matini, Habibollah Rahimi, Majid Lotfinia, Hossein Motedayyen, Leyla Sadat Hejazi   +5 more
wiley   +1 more source

Indicators to identify cancer screening providers with suboptimal case detection: A scoping review

International Journal of Cancer, Volume 158, Issue 9, Page 2339-2358, 1 May 2026.
What's new? Quality control of cancer screening programs is essential to maintaining high public health standards. Here, the authors reviewed monitoring of case detection in cervical and colorectal cancer screening programs in Europe, and evaluated its effectiveness. They analysed 20 different measures used for this purpose and showed that many of them
Jiayao Lei, Milena Falcaro, Adam R. Brentnall, James F. O'Mahony, Sisse Helle Njor, Matejka Rebolj   +5 more
wiley   +1 more source